Literature, news and videos pertinent to
The Fred Runnels Padgett
Lung Cancer Patient Advocacy Program

PAPILLON: Adding Amivantamab to First-Line Chemotherapy Prolongs Progression-Free Survival in NSCLC Subset
By The ASCO Post Staff
December 10, 2023 - Supplement: ESMO Highlights

National Lung Screening Trial Results Highlight Importance of Lifelong Follow-up
By The ASCO Post Staff
October 10, 2022 - Supplement: Conference Highlights IASLC 2022

Screening for Lung Cancer with Low Dose Computed Tomography (LDCT)CMS.gov Centers for Medicare & Medicaid Services

INHERIT EGFR - Studying Germline EGFR Mutations (INHERIT)ClinicalTrials.gov

powered by Surfing Waves

We are always looking for updated RSS newsfeeds for the The Fred Runnels Padgett Lung Cancer Patient Advocacy Program at ICAN. If you have suggestions, please email us at FredPadgettProgram@askican.org.

Please encourage family and friends to join our Cancer Research Literature teams for this Program by emailing ICAN at FredPadgettProgram@askican.org.  We would like additional Research Team Leaders at ICAN for this named program to be medical students, physicians, nurses, or post-doctoral students in the sciences.  

Web Research Interns for the The Fred Runnels Padgett Lung Cancer Patient Advocacy Program are comprised of highly motivated high school students, college students, college graduates, medical students, or employed or retired persons who have the time to help a great cause.  

Please submit two paragraphs about your background and career (and career aspirations) and why you would like to be part of an ICAN Research team.  All positions are "virtual" meaning you work from your home or office computer and email your work in Word (and in some cases Excel, but you need not be fluent in Excel to join us).  

Because ICAN has a global volunteer network, all positions are unpaid.  ICAN is five-star rated on VolunteerMatch.

If you have peer-reviewed citations to SUBMIT to this part of Fred's Program, please email to CitationReviewFredPadgett@askican.org.